Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

BACKGROUND: The study of cyclooxygenase-2 (COX-2) inhibitors is now mired in controversy. We performed a meta-analysis to assess the efficacy and safety profile of COX-2 inhibitors in patients with advanced non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: A literature search of PubMed, EMBA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Ping, Li, Jing, Ma, Xiao-Ping, Huang, Jian, Meng, Juan-Juan, Gong, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804138/
https://www.ncbi.nlm.nih.gov/pubmed/29440919
http://dx.doi.org/10.2147/OTT.S148670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804138/
https://www.ncbi.nlm.nih.gov/pubmed/29440919
http://dx.doi.org/10.2147/OTT.S148670

Ejemplares similares